Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2018 | 08-2018 | 05-2018 | 02-2018 | 11-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,645 | 1,727 | 2,063 | 2,318 | 0 |
| Marketable Securities | 71 | 10 | 18 | N/A | 0 |
| Receivables | 215 | 266 | 268 | 188 | 0 |
| Inventories | 117 | 87 | 77 | 63 | 0 |
| TOTAL | $3,231 | $2,284 | $2,587 | $2,745 | $0 |
| Non-Current Assets | |||||
| PPE Net | 123 | 1 | 1 | 2 | N/A |
| Intangibles | 190 | 147 | 121 | 94 | 0 |
| TOTAL | $313 | $148 | $122 | $96 | $N/A |
| Total Assets | $3,544 | $2,432 | $2,709 | $2,841 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 108 | 36 | 63 | 63 | 0 |
| TOTAL | $130 | $44 | $72 | $69 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $130 | $44 | $72 | $69 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,579 | N/A | 2,436 | 2,390 | N/A |
| Common Shares | 77 | 76 | 72 | 71 | 0 |
| Retained earnings | -20,470 | -19,769 | -18,552 | -15,127 | 0 |
| Other shareholders' equity | 0 | -14 | -7 | 0 | 0 |
| TOTAL | $3,414 | $2,388 | $2,637 | $2,772 | $0 |
| Total Liabilities And Equity | $3,544 | $2,432 | $2,709 | $2,841 | $0 |